Besponsa (inotuzumab ozogamicin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Besponsa (inotuzumab ozogamicin), covering 2026-03-31 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy [Phase 3]